Decreased Phagocytic Function in Patients with Parkinson's Disease
Overview
General Medicine
Pharmacology
Authors
Affiliations
To determine the phagocytic function of the peripheral blood polymorphonuclears from patients with treated and untreated Parkinson's disease (PD), these cells were incubated with latex particles and the number of phagocytes, as well as the number of particles engulfed by each individual cell, were counted. Cells of untreated PD patients were significantly less phagocytotic than those of matched subjects without neurological or immune disorders (24% vs. 45%, P < 0.001). In addition, phagocytes from PD patients engulfed less particles per cell than those of the controls (8.4 +/- 0.7 vs. 16.5 +/- 1.3, P < 0.001). There was no significant difference in both functions in untreated and treated PD. The results indicate that in addition to the known immune alterations in patients with PD, the ability of their peripheral blood phagocytic cells to engulf latex particles is impaired.
Bhatia T, Jamenis A, Abbas M, Clark R, Miner K, Chandwani M Neurobiol Dis. 2023; 184:106196.
PMID: 37315905 PMC: 10528721. DOI: 10.1016/j.nbd.2023.106196.
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?.
Janda E, Boi L, Carta A Front Mol Neurosci. 2018; 11:144.
PMID: 29755317 PMC: 5934476. DOI: 10.3389/fnmol.2018.00144.
Lecca D, Janda E, Mulas G, Diana A, Martino C, Angius F Br J Pharmacol. 2018; 175(16):3298-3314.
PMID: 29570770 PMC: 6057897. DOI: 10.1111/bph.14214.
Boyko A, Troyanova N, Kovalenko E, Sapozhnikov A Int J Mol Sci. 2017; 18(12).
PMID: 29211044 PMC: 5751236. DOI: 10.3390/ijms18122633.
Parkinson's disease: experimental models and reality.
Jiang P, Dickson D Acta Neuropathol. 2017; 135(1):13-32.
PMID: 29151169 PMC: 5828522. DOI: 10.1007/s00401-017-1788-5.